₹1035*
MRP ₹1150
10% off
₹977.5*
MRP ₹1150
15% CB
₹172.5 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
coupon
Prescription drugWhats That
Composition :
Manufacturer/Marketer :
Consume Type :
Return Policy :
Expires on or after :
Secure Payment
Trusted by 8 Crore Indians
Genuine Products
Author Details
.jpg?tr=q-80,f-webp,w-100,dpr-6,c-at_max "Lakshmithulasi Yarragunta")
Disclaimer
Alcohol
Unsafe
Consuming alcohol or other illicit drugs during treatment with Zuprinor 10 Transdermal Patch increases your chances of experiencing these significant, life-threatening adverse effects. Throughout your therapy, do not consume alcohol, use alcohol-containing prescription or nonprescription medicines, or use street drugs.
Pregnancy
Unsafe
If you are pregnant or planning pregnancy, inform your doctor. If you use Zuprinor 10 Transdermal Patch often throughout your pregnancy, your baby may suffer from potentially fatal withdrawal symptoms after birth. If your infant exhibits any of the following symptoms, contact your doctor straight away: irritability, hyperactivity, disturbed sleep, high-pitched scream, excessive shaking of a portion of the body, vomiting, diarrhoea, or failure to gain weight.
Breast Feeding
Unsafe
If you are nursing, you should avoid using Zuprinor 10 Transdermal Patch. Buprenorphine passes into breast milk in small amounts and might cause respiratory issues in your infant. Talk with your doctor; they may prescribe a different pain reliever.
Driving
Unsafe
Zuprinor 10 Transdermal Patch may cause dizziness, blurred vision or drowsiness in some people. Therefore, avoid driving if you feel drowsy, dizzy or experience any vision problems after using Zuprinor 10 Transdermal Patch.
Liver
Caution
If you have a pre-existing or a history of liver disease, inform your doctor before using Zuprinor 10 Transdermal Patch.
Kidney
Caution
If you have a pre-existing or a history of kidney disease, inform your doctor before using Zuprinor 10 Transdermal Patch.
Children
Unsafe
Zuprinor 10 Transdermal Patch is not recommended for children below 18 years of age as safety and effectiveness have not been established.
Product Substitutes
Drug-Drug Interactions
Drug-Drug Interactions
Login/Sign Up
Using alvimopan together with Zuprinor 10 Transdermal Patch can cause side effects (abdominal pain, nausea, vomiting, and diarrhea).
How to manage the interaction:
Taking Alvimopan with Zuprinor 10 Transdermal Patch is not recommended, consult a doctor before taking it. Do not stop using any medications without talking to a doctor.
Taking Ziprasidone with Zuprinor 10 Transdermal Patch can increase the risk of serious side effects.
How to manage the interaction:
Taking Ziprasidone with Zuprinor 10 Transdermal Patch is not recommended, but it can be taken together if prescribed by a doctor. However, consult a doctor if you experience dizziness, drowsiness, difficulty concentrating, and impairment in judgment. Do not discontinue any medications without consulting a doctor.
Using Zuprinor 10 Transdermal Patch together with Mephenytoin can cause central nervous system depression (a physiological state that can result in a decreased rate of breathing, decreased heart rate, and loss of consciousness).
How to manage the interaction:
Although there is a possible interaction between Mephenytoin and Zuprinor 10 Transdermal Patch, you can take these medicines together if prescribed by a doctor. It's important to keep an eye on your health and be aware of any changes. If you experience tiredness or having trouble breathing, make sure to contact a doctor right away. Do not stop using any medications without talking to a doctor.
Using Zuprinor 10 Transdermal Patch together with sodium valproate may increase the risk of severe side effects, including respiratory problems and loss of consciousness.
How to manage the interaction:
Although the administration of Zuprinor 10 Transdermal Patch alongside sodium valproate can result in an interaction, it can be taken if a doctor has advised it. However, if you experience sudden dizziness, lightheadedness, fainting, shortness of breath, chest pain or tightness, rapid heartbeat, or memory loss, contact a doctor immediately. Do not discontinue any medications without consulting a doctor.
Taking Zuprinor 10 Transdermal Patch with anagrelide increases the risk of an abnormal heart rhythm.
How to manage the interaction:
Concomitant administration of Zuprinor 10 Transdermal Patch with anagrelide can result in an interaction, it can be taken if a doctor has advised it. However, if you experience abrupt dizziness, lightheadedness, fainting, shortness of breath, or rapid heartbeat, get medical help immediately. Do not discontinue any medications without consulting a doctor.
When Zuprinor 10 Transdermal Patch is used with topiramate, it may lead to significant adverse effects such as respiratory difficulties, unconsciousness.
How to manage the interaction:
Concomitant administration of Zuprinor 10 Transdermal Patch alongside topiramate can result in an interaction, it can be taken if a doctor has advised it. Do not exceed the doses, frequency, or duration of usage advised by a doctor. You should avoid driving or operating hazardous machinery until you're aware of how these medications effect you. Consult a doctor if you have any questions or concerns. Do not discontinue any medications without consulting a doctor.
When Zuprinor 10 Transdermal Patch is used with Clonazepam, it may lead to significant adverse effects such as respiratory difficulties.
How to manage the interaction:
Co-administration of Zuprinor 10 Transdermal Patch alongside Clonazepam can result in an interaction, it can be taken if a doctor has advised it. Do not exceed the doses, frequency, or duration of usage advised by a doctor. You should avoid driving or operating hazardous machinery until you know how these drugs affect you. Do not discontinue any medications without consulting a doctor.
When Zuprinor 10 Transdermal Patch is used with gatifloxacin, it may lead to significant adverse effects (respiratory difficulties or unconsciousness).
How to manage the interaction:
Concomitant administration of Zuprinor 10 Transdermal Patch alongside gatifloxacin can result in an interaction, it can be taken if a doctor has advised it. However, if you experience sudden dizziness, lightheadedness, fainting, shortness of breath, chest pain or tightness, rapid heartbeat, or memory loss, contact a doctor immediately. Do not discontinue any medications without consulting a doctor. You should avoid driving or operating hazardous machinery while taking these medications.
Coadministration of Zuprinor 10 Transdermal Patch with tranylcypromine may increase the risk of significant adverse effects such as respiratory depression(breathing problems), low blood pressure, fainting, unconsciousness
How to manage the interaction:
Concomitant administration of Zuprinor 10 Transdermal Patch alongside tranylcypromine can result in an interaction, it can be taken if a doctor has advised it. Do not discontinue any medications without consulting a doctor.
Using Zuprinor 10 Transdermal Patch together with Clomipramine can cause central nervous system depression (a physiological state that can result in a decreased rate of breathing, decreased heart rate, and loss of consciousness).
How to manage the interaction:
Although taking clomipramine and Zuprinor 10 Transdermal Patch together can cause an interaction, it can be taken if a doctor has suggested it. However, contact a doctor immediately if you experience any symptoms such as confusion, hallucinations, seizures, changes in blood pressure, increased heart rate, fever, excessive sweating, shivering or shaking, blurred vision, muscle spasm or stiffness, tremor, incoordination. Do not discontinue any medications without consulting a doctor.
Drug-Food Interactions
Drug-Food Interactions
Login/Sign Up
Drug-Diseases Interactions
Drug-Diseases Interactions
Login/Sign Up
Have a query?